Researchers from Harvard Medical School have developed an AI model, Clinical Histopathology Imaging Evaluation Foundation (CHIEF), which can analyse multiple forms of cancer with great versatility and accuracy. CHIEF can predict patient outcomes and validate its results across different international groups. Unlike similar models based on pathology images, the system can predict patient outcomes and validate results across various patient groups. The model works by reading digital slides of tumour tissues, identifying genes and DNA patterns related to treatment responses.
The True Cost of Focusing on Cost Instead of Cost-Effectiveness
When payors consider only the cost of the medication and not the cost and risk to the patient, doctor, and healthcare system, the irony is
